212Pb/212Bi‐EDTMP — synthesis and biodistribution of a novel bone seeking alpha‐emitting radiopharmaceutical
- 1 August 1994
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 34 (8) , 717-734
Abstract
At present, haematological toxicity is dose limiting in radionuclide therapy of bone metastases, and there is a need for radiopharmaceuticals with improved tumour/bone marrow dose ratios. Therefore, α‐emitters e.g. 212Bi may be more suitable than β‐emitters, because of the short range and high LET values of α‐particles. In this study, 212Bi and its mother nuclide 212Pb were produced in an isotope generator by collecting gaseous 220Rn emanating from barium (228Th) stearate. The carrier‐free 212Pb/212Bi were bound to the chelating bone‐seeking compound ethylene‐diamine‐tetra(methylene‐phosphonic acid) (EDTMP) with 90% yield. The biodistribution in Balb/c mice was investigated by injecting 100 μl of a saline PBS buffer 0.020 M in EDTMP and 10 MBq/ml in 212Pb/212Bi. Mice were killed in groups of three at 0.5, 2, 13 and 24 h post‐injection times. Both 212Pb‐EDTMP and 212Bi‐EDTMP localised strongly in the skeleton, especially in the femur, at all time points measured, with the % of injected dose per gram (%ID/g) as high as 15 for 212Pb and 13 for 212Bi. All other organs investigated showed low uptake of both radionuclides, with the exception of the kidneys, for which a ratio femur/kidney of 1.5 for 212Bi 2 h postinjection was observed. By comparison the ratio femur/blood was 20 for 212Bi 2 h postinjection. The experiment indicates a potential for 212Pb/Bi‐EDTMP in targeted radiotherapy of osteoblastic bone lesions.Keywords
This publication has 13 references indexed in Scilit:
- A Model of Cell Inactivation by Alpha-Particle Internal EmittersRadiation Research, 1993
- The Chemical Fate of 212Bi-DOTA Formed by β- Decay of 212Pb(DOTA)2-***Radiochimica Acta, 1993
- Targeted radionuclide therapy for bone metastasesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD), in rats and miceToxicology, 1990
- Resident's essay award: Alpha particle radio-immunotherapy: Animal models and clinical prospectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- The development of α-emitting radionuclide lead 212 for the potential treatment of ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1989
- A remote system for the separation of228Th and224RaJournal of Radioanalytical and Nuclear Chemistry, 1987
- Preparation of a dry 228Th source of thoronJournal of Inorganic and Nuclear Chemistry, 1967
- The Direct Synthesis of α-Aminomethylphosphonic Acids. Mannich-Type Reactions with Orthophosphorous AcidThe Journal of Organic Chemistry, 1966
- The diffusion of thoron in solids. Part II—the emanating power of barium salts of the fatty acidsTransactions of the Faraday Society, 1951